September 25, 2018

WIPO and IFPMA Launch New Online Patent-Search Resource to Help Health Agencies Procure Medicines

(AETOS Wire)-- WIPO and the research-based pharmaceutical industry today launched a new online tool designed to help procurement agencies better understand the global patent status of medicines.

The"...

September 23, 2018

Takeda Receives Positive CHMP Opinion Recommending ALUNBRIG® (brigatinib) for the Treatment of ALK+ Non-Small Cell Lung Cancer in Patients Previously Treated with Crizotinib

(AETOS Wire) -- Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion, recommending the full approval of ALUNBRIG®(brigatinib) as a monotherapy for the treatment of adult patients with anaplastic lymphoma kinase-positive (ALK+) advanced non-small cell lung cancer (NSCLC) previously treated with crizotinib. ALUNBRIG is a tyrosine kinase inhibitor (TKI) designed to target and inhibit the ALK mutation in NSCLC. Approximately three to five percent of NSCLC patients globally have the ALK mutation. If......

September 20, 2018

“Man of The Planet” Sergey Burlakov Visits Dubai Sports Medicine Facility

Sergey Burlakov, a Paralympic athlete and four-time amputee, visited nanoM on September 16th. nanoM is a sports and human performance facility that is the first of its kind in the world, and Burlakov visited to undergo a series of tests.

Karan"...

September 19, 2018

175 Million Europeans Have Sleep Apnoea, Highlighting Scale of Global Health Crisis

(AETOS Wire)-- Roughly 175 million Europeans have obstructive sleep apnoea, according to a late-breaking abstract presented by ResMed today at the European Respiratory Society’s annual ERS Congress in Paris. Leading researchers estimate 90"...

September 17, 2018

Large European real-world study reports effects of Spiolto® Respimat® for people living with COPD in daily clinical practice1

(AETOS Wire)-- Boehringer Ingelheim announced results from the OTIVACTO study, an observational European real-world study of 7,443 Chronic Obstructive Pulmonary Disease (COPD) patients treated with Spiolto® (tiotropium/olodaterol) Respimat®,"...

September 17, 2018

MEDTEX: Foresee the Next Wave of Healthcare Revolution

(AETOS Wire)-- Taiwan, with high quality medical service and world’s top IT industry, has becoming one of the leaders in global healthcare technology and provider. On November 29 - 30, MEDTEX will focus on 3 key trends: Intelligent Healthcare,"...

September 17, 2018

Biolog-id Branches out to the United States with a New Operational Center in Atlanta

(AETOS Wire)-- Biolog-id, a world leader in connected health solutions, today announced the establishment of its U.S. operational center in Atlanta. This new site will enable Biolog-id to continue the growth of its presence in North America and offer"...

September 16, 2018

Clinical trial data for nintedanib in patients with advanced IPF published

• INSTAGE® trial results published in the New England Journal of Medicine1

• Trial provides clinical data on patients with IPF and severe impairment in gas exchange usually excluded from clinical trials1
• Efficacy and safety profile of nintedanib in patients with advanced IPF was consistent with that observed in patients...
  Read More >>

September 16, 2018

Opt for Stromal Vascular Fraction (SVF) Therapy to Treat Chronic Pain

A 31-year-old Caucasian male, a baseball player, was extremely active athletically and in great physical shape until he was struck with osteoarthritis of the right shoulder and left knee. While the young sportsman wanted to build his career in baseball, the increasing pain levels made it"...

September 14, 2018

ResMed Introduces Its First Minimal-contact Full Face CPAP Mask, AirFit F30

ResMed (NYSE: RMD) (ASX: RMD) today introduced its first minimal-contact full face CPAP mask, AirFit F30, the latest addition to its AirFit mask portfolio, which helps users reduce facial marks, wear glasses in bed and curl up closer to their bed partner.

Unlike"...